JPRN-UMIN000006662招募中未知
Additive effect of Lipid-Lowering by atrovaSTatin on Amelioration of Renal hemodynamic in patients with CKD - Additive effect of Lipid-Lowering by atrovaSTatin on Amelioration of Renal hemodynamic in patients with CKD(ALL-STAR-CKD)
Departmrnt of CKD initiatives,Nagoya university graduate school of medicine0 个研究点目标入组 120 人开始时间: 2011年11月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Defective diabetic for control(abobe FBS160mg/dL,HbA1c8%) 2)Familial hypercholesteremia. 3)The past of event of cardiovascular disease. 4)High blood pressure that cannot be controlled(above 140mg/dL) 5)Patient who has previous history of hypersensitivity for Atolbastatin or Ezetimibe 6)Woman who has pregnant woman or possibility of pregnancy 7)Patient who judged that it is improper that physician in charge puts it in to examination
研究者
相似试验
进行中（未招募）
1 期
Effect of Intensive cholesterol-lowering medication on blood flow in the coronary arteries in patients with coronary artery disease.EUCTR2019-001912-50-DKDepartment of Cardiology, Aarhus University Hospital, Denmark120
招募中
不适用
Effectiveness Of Atorvastatin On Dyslipidemic Erectile Dysfunction PatientsErectile dysfunctionJPRN-UMIN000038823Kasr Alainy faculty of medicine60
招募中
不适用
Effect of Lipid lowering Drug vAtorvastatin in Steroid resistance Nephrotic syndromeCTRI/2012/07/002761ICMR50
已完成
不适用
Effects of lipid lowering by atorvastatin on carotid atherosclerotic plaque (ACAP) study: a randomized trial for analysis of qualitative change in carotid atherosclerrotic plaque with IB echo and Black Blood MRICarotid artery stenosisJPRN-UMIN000001114Gifu University Graduate School of Medicine Department of Neurosurgery100
已完成
不适用
Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary SyndromeAcute coronary syndromeJPRN-UMIN000002742Department of Cardiology, Tokyo Women's Medical University3,000